Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: The Combination Effect of Statin Plus Metformin on Relapse-free [Phase 2]
A Phase 2 clinical trial assessing the combination of a statin and metformin for relapse-free survival in hepatocellular carcinoma has been …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Statin With Palliative Therapy for HCC [NA]
A clinical trial evaluating statin in combination with palliative therapy for hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
A completed clinical trial evaluated using multi-spectral CT to stratify patients with chronic liver disease, including hepatocellular carci…
-
CLINICAL_TRIALS withdrawal · 2017-04-13Clinical Trial Update: Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients
A clinical trial investigating the role of hepatocyte SLAMF3 receptor and MDR proteins in sorafenib resistance in hepatocellular carcinoma p…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: the Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC. [NA]
This clinical trial compares Grazoprevir/Elbasvir plus TACE to TACE alone in patients with non-resectable HCV-associated hepatocellular carc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
A completed clinical trial analyzing urinary proteases as potential biomarkers for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2017-04-12Clinical Trial Update: Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma
This clinical trial update concerns methods for preoperatively estimating microvascular invasion in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: ISP-TACE Versus TACE for HCC With PVTT
A completed clinical trial comparing ISP-TACE with conventional transarterial chemoembolization (TACE) in hepatocellular carcinoma with port…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy [NA]
A clinical trial update suggests that implementing an Enhanced Recovery After Surgery (ERAS) program improves postoperative recovery for pat…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)
A completed clinical trial investigating the use of MRI-only planning for liver stereotactic body radiation therapy (SBRT).
-
CLINICAL_TRIALS withdrawal · 2017-03-30Clinical Trial Update: Resveratrol and Human Hepatocyte Function in Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial of resveratrol for hepatocyte function in liver cancer was withdrawn. The sponsor was the University of Louisvill…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy [Phase 1]
A multicenter, open-label Phase 1 study in Japan evaluated the MEK inhibitor pimasertib in patients with advanced solid tumors; the trial wa…
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma [Phase 3]
A Phase 3 trial evaluating sorafenib as first-line therapy for advanced hepatocellular carcinoma in adults was terminated.
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: Combined Treatment of RFA and Sorafenib on Recurrent HCC [NA]
Update on a clinical trial evaluating the combination of radiofrequency ablation and sorafenib for recurrent hepatocellular carcinoma. The c…
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE [NA]
A clinical trial evaluating the combination of radiofrequency ablation and postoperative transarterial chemoembolization for hepatocellular …
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC [NA]
The document reports a clinical trial examining radiofrequency ablation with sorafenib for early to intermediate hepatocellular carcinoma. T…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) [Phase 3]
Phase 3 study results for ThermoDox in combination with radiofrequency ablation in hepatocellular carcinoma have been completed, with result…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: HCC Response Assessment by MRI After SBRT
This is a completed clinical trial update. The study evaluates MRI-based response assessment for hepatocellular carcinoma after stereotactic…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer [Phase 1]
A Phase 1 safety and efficacy study of CC-122 in combination with sorafenib for hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS research · 2017-03-20Clinical Trial Update: Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
This entry describes an ongoing Phase 1/2 clinical trial of an anti-GPC3 CAR-T cell therapy for GPC3-positive advanced hepatocellular carcin…
-
CLINICAL_TRIALS research · 2017-03-17Clinical Trial Update: Central Obesity and Hepatocellular Carcinoma
This clinical trial update investigates the relationship between central obesity and hepatocellular carcinoma; the status of the trial is li…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma [Phase 3]
Phase 3 trial evaluating the combination of transarterial chemoembolization with recombinant human adenovirus for hepatocellular carcinoma; …
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) [Phase 2]
Phase 2 trial update reporting completion of a study on a modified-process Hepatitis B vaccine in healthy neonates.
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. [Phase 3]
Phase 3 trial update of Civacir, a polyclonal IgG, to prevent hepatitis C virus recurrence in liver transplant patients; study status is com…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer [NA]
An update on a clinical trial evaluating the efficacy and safety of CAR-T cell therapy for liver cancer; the current trial status is not spe…